
An employee of the anti-plague institute was previously diagnosed with pneumonia of unknown etiology
In the Irkutsk region, medical observation of 60 percent of people who had contact with an employee of the anti-plague institute, who was hospitalized with pneumonia of unknown etiology and died on October 2, has been completed.
AI-generated summary
An employee of the anti-plague institute in the Irkutsk region was hospitalized with pneumonia and died on October 2.
In the Irkutsk region, medical observation of 60 percent of people who had contact with an employee of the anti-plague institute, who was diagnosed with pneumonia of unknown etiology, was completed. Rospotrebnadzor reported this, TASS reports.
It is noted that the decision to end the observation was made after receiving the results of laboratory tests and assessing the health status of people. The department emphasized that the situation remains under control.
On October 2, it became known that an employee of the anti-plague institute in the Irkutsk region ended up in the hospital and could not be saved. After this, a number of publications published reports that the Russian woman could have contracted pneumonic plague while performing her official duties, and about 200 people were quarantined. Later, Rospotrebnadzor clarified that the woman was diagnosed with pneumonia of unknown etiology.

More than 1,900 children in eastern DRC have lost parents or guardians due to the Ebola epidemic. According to UNICEF, as of September 29, there were 2,076 confirmed cases among children, of which at least 1,162 had died.

Kenya has reported its first case of Ebola fever, and the patient died in a Nairobi hospital. Authorities are searching for 23 passengers and four crew members of the flight.

In the United States, 45-year-old Holly LaPrade was diagnosed with a rare genetic disease - fibrodysplasia ossificans progressive, in which new bones grow in the muscles, creating a second skeleton.

Kenya's Ministry of Health has confirmed the country's first case of the Bundibugyo strain of Ebola virus in a patient who arrived from DR Congo via Uganda.

The Russian Ministry of Health has registered the drug Elefuza (fusuloparib), developed by Petrovax Pharm with Chinese partners, for the treatment of aggressive forms of breast and ovarian cancer.

Moscow doctors from the Veresaev City Clinical Hospital successfully performed a hip replacement operation on a 67-year-old patient from Austria who suffered from arthrosis. Because the woman had a defibrillator, doctors used a special plasma instrument.